What GE Healthcare does

GE HealthCare Technologies Inc. (NASDAQ: GEHC) is a global medical technology and pharmaceutical diagnostics company headquartered in Chicago and spun off from General Electric in January 2023. The company designs, manufactures, and services a broad portfolio of medical imaging, ultrasound, patient care, and molecular imaging products used by hospitals, integrated delivery networks, specialty practices, and outpatient/ambulatory providers across more than 20 country markets. It serves over 1 billion patients annually through a 5M+ installed base of capital equipment, with named customers including HCA Healthcare, Sutter Health, Tampa General Hospital, Memorial Sloan Kettering, and academic medical centers such as the University of Cincinnati and Cincinnati Children's.

The company's core technology combines AI-native medical imaging devices with cloud-enabled software platforms. Proprietary deep-learning reconstruction algorithms (AIR Recon DL, Sonic DL, TrueFidelity, Pristina Recon DL) are embedded across MRI, CT, ultrasound, and mammography systems, complemented by the helium-free Freelium MRI magnet, photon-counting Deep Silicon CT, the Edison Digital Health Platform, Genesis Solutions, CareIntellect, and Command Center hospital operations software. Recent acquisitions (Caption Health, Intelligent Ultrasound, MIM Software, and the pending Intelerad deal) extend the company into AI-enabled ultrasound guidance, radiation oncology auto-contouring, and cloud-based enterprise imaging for ambulatory settings. It holds 110-120 FDA AI-enabled medical device authorizations, leading the industry for four consecutive years.

Revenue is generated through capital equipment sales (MRI, CT, PET/CT, ultrasound, mammography, surgical imaging, image-guided therapy), recurring service and maintenance contracts on the installed base (representing roughly half of total revenue), subscription-based access via Smart Subscription for CT and molecular imaging, software and AI solutions, pharmaceutical diagnostics consumables (contrast media, radiopharmaceuticals), Healthcare Financial Services for equipment financing, and clinical education programs. The go-to-market model is primarily enterprise field sales supported by Healthcare Financial Services, an e-commerce storefront for handheld ultrasound and accessories, self-serve demo booking, and country-specific local sites. Management is led by President and CEO Peter Arduini and CFO James Saccaro; the company maintains a $22B order backlog supporting growth into 2026.

Name

GE Healthcare

Legal name

GE HealthCare Technologies Inc.

Website

https://gehealthcare.com

Company type

Public

Founded year

2023

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

GE HealthCare is a global medical technology company that designs, manufactures, and services imaging equipment (MRI, CT, ultrasound, PET/CT, mammography), patient monitoring, AI-enabled clinical software, and pharmaceutical diagnostics for hospitals, health systems, and specialty providers worldwide.

Ownership category

akta.pro rank

Product category

Medical Imaging Equipment

NAICS

Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)

akta.pro secondary industry

Medical Imaging AI (HDAAAEAH)

Keywords

• Medical imaging equipment
• Ultrasound systems
• Healthcare AI software
• Contrast media diagnostics
• Patient monitoring solutions

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Capital Equipment Sales (Imaging, Ultrasound, Patient Care): One-time hardware sales of MRI (SIGNA), CT (Revolution/Photonova), PET/CT (Omni Legend, Discovery MI), Mammography (Senographe Pristina), Ultrasound (Vivid, LOGIQ, Voluson, Venue, Vscan), Surgical Imaging (OEC), Image Guiding Solutions (Allia), and patient care solutions (anesthesia, monitoring, maternal-infant care).
2. Recurring Service & Maintenance Contracts: Service contracts on installed base equipment (5M+ installed base), which represents approximately half of total revenue alongside recurring software and consumables streams.
3. Smart Subscription Services: Industry's first subscription-based service for CT and MI applications, continually updating devices with latest applications across entire fleets.
4. Software & AI Solutions (Enterprise Imaging, PACS, AI Orchestration): Recurring software and AI revenue from Edison Digital Health Platform, Genesis Solutions, CareIntellect, Command Center, MIM Software, Verisound, Datalogue (Enterprise Imaging VNA), and other digital offerings.
5. Pharmaceutical Diagnostics (Contrast Media & Molecular Imaging Agents): Consumables including iodine-based contrast media (FAMAR contract manufacturing agreement to produce in Homburg, Germany, 25M patient doses by 2031), radiopharmaceuticals (Flyrcado, Vizamyl), and molecular imaging agents supporting nuclear medicine procedures.
6. Clinical Education & Training (HelloAI Professional): Free 20-hour healthcare AI training program (HelloAI Professional) and paid clinical/professional development education services; Healthcare Learning System (HLS) platform.
7. Biomedical Services Contracts: Third-party biomedical equipment maintenance and service contracts (e.g., InfuSystem Holdings restructured its GE Healthcare biomedical services contract in Q1 2026).
8. Healthcare Financial Services: Equipment financing, leasing, and Refresh Financial Services supporting capital purchases by healthcare providers.

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels8 records

Core offering

GE HealthCare designs, manufactures, and sells medical imaging equipment (MRI, CT, PET/CT, X-ray, mammography, surgical C-arms, image-guided therapy systems), ultrasound systems (cardiovascular, general imaging, women's health, point-of-care, handheld), patient care solutions (anesthesia, monitoring, maternal-infant care), and pharmaceutical diagnostics (contrast media and molecular imaging agents). The portfolio is complemented by software/AI platforms including enterprise imaging, hospital operations (Command Center), and advanced visualization, sold primarily to hospitals and healthcare providers globally under capital sales, service contracts, and subscription models.

Product overview

GE HealthCare operates as a multi-modality medical technology and pharmaceutical diagnostics company spun off from General Electric in early 2023. Its product portfolio follows a platform-plus-modules architecture spanning four major categories: (1) Imaging — including the SIGNA MR portfolio (SIGNA Sprint with Freelium, SIGNA Bolt, SIGNA One, SIGNA Champion AI, SIGNA 7T, SIGNA PET/MR AIR), the Revolution CT family (Photonova Spectra, Revolution Apex, Revolution Frontier Gen 3, Revolution Ascend/Maxima/RT, Revolution Apex Edge photon-counting), the Definium X-Ray family, the Senographe Pristina mammography portfolio (with Pristina Recon DL), the Molecular Imaging portfolio (Omni Legend, Discovery MI Gen 2, Discovery IQ Gen 2, NM/CT 870 CZT, Xeleris V, MotionFree), the MIM Software suite (MIM Encore, MIM SurePlan MRT, LesionID Pro, MIMneuro), the Allia IGS interventional portfolio (Allia IGS 5/7/Pulse/Moveo), the invasive cardiology Mac-Lab/CardioLab/ComboLab systems, the OEC C-arm surgical imaging family, and the Lunar DXA bone health systems; (2) Ultrasound — the Vivid cardiovascular series, the LOGIQ general imaging family, the Voluson women's health line, the Venue point-of-care family, the Vscan Air handheld systems, Invenia ABUS Premium for breast, and Versana primary care; (3) Software & AI Solutions — the cloud-enabled Genesis Radiology Workspace, Datalogue Enterprise Imaging VNA, Command Center (deployed by 300+ health systems), CareIntellect, Centricity Cardiology IT, Verisound Digital & AI Ultrasound Solutions, AW Family advanced visualization applications, MIM Software, and the upcoming Edison Digital Health Platform developer ecosystem; and (4) Pharmaceutical Diagnostics — contrast media and molecular imaging agents including Flyrcado (cardiac PET) and Vizamyl (Alzheimer's). Predictive Services (OnWatch Predict, Tube Watch), ReadySee asset management, Portrait Mobile wireless monitoring, and STRATUM MTAS services round out the platform, which is reinforced by partnerships and acquisitions including MIM Software, Intelerad (pending close), Caption Health, Intelligent Ultrasound Group, and BK Medical. GE HealthCare leads the FDA's list of AI-enabled medical device authorizations with 120+ approvals and ~$5.1B in annual R&D investment since 2022.

Differentiator

Problem solved

Functional benefit

Brands

• SIGNA: Family of MRI scanners and workflow solutions (1.5T, 3T, 7T, PET/MR), including SIGNA Sprint, SIGNA Bolt, SIGNA One, SIGNA Champion, and the SIGNA MAGNUS head-only MR system.
• LOGIQ
• Vivid
• Voluson
• Vscan Air
• Venue
• Versana
• Invenia
• Revolution
• Definium
• Omni Legend
• Discovery
• StarGuide
• OEC
• Allia
• Senographe Pristina
• Mac-Lab
• MIM Software
• Verisound
• Lunar
• Caption AI

Products and services

• SIGNA MR (MRI Portfolio) GE HealthCare's MRI portfolio of 1.5T, 3T, 7T, and PET/MR scanners including SIGNA Sprint with Freelium, SIGNA Bolt, SIGNA One, SIGNA Premier, SIGNA Champion AI, SIGNA 7T, SIGNA PET/MR AIR, and the investigational SIGNA MAGNUS head-only scanner. Features AIR Recon DL deep-learning reconstruction and Sonic DL acceleration.
• Revolution CT (Computed Tomography Portfolio) CT portfolio including Photonova Spectra (photon-counting CT with Deep Silicon technology), Revolution Apex platform, Revolution Vibe (cardiac CT), Revolution Frontier Gen 3 with Spectral CT, Revolution Ascend (AI-based workflow), Revolution Maxima, Revolution RT (radiation therapy), and Revolution Apex Edge photon-counting CT. Powered by TrueFidelity DLIR deep-learning reconstruction.
• Definium X-Ray Portfolio

Quantifiable outcome

• ~$5.1B annual R&D investment since 2022
• +11 more outcomes

Named customers9 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability14 records

Feature15 records

Scale indicators15 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Fujifilm Healthcare: Competitor in diagnostic imaging (MRI, CT, X-ray), endoscopy, ultrasound, and enterprise imaging (Synapse PACS), with overlapping AI imaging analytics offerings for hospitals.
• Siemens Healthineers: Direct competitor across MRI (MAGNETOM), CT (NAEOTOM photon-counting Alpha), molecular imaging, ultrasound, and AI-enabled imaging software; explicitly cited as #2 to GE HealthCare in FDA AI medical device authorizations and a co-participant in the global photon-counting CT market development.
• Canon Medical Systems: Direct competitor in CT, MRI, ultrasound, and X-ray imaging systems for hospitals and health systems globally, with overlapping AI-enabled imaging product lines.
• Philips Healthcare: Direct competitor in MRI, CT, ultrasound, image-guided therapy, and enterprise imaging/PACS; partner alongside GE HealthCare in deploying agentic AI clinical tools and explicitly cited in the FDA AI authorization rankings alongside GE.
• Varian (Siemens Healthineers): Direct competitor in radiation oncology treatment planning and AI-enabled auto-contouring, where it overlaps with GE HealthCare's MIM Software suite (MIM Contour ProtégéAI+, MIM SurePlan MRT, LesionID Pro) post-MIM acquisition.

Emerging players

• Hologic: Closest peer in women's health imaging, particularly mammography/breast biopsy where it competes with Senographe Pristina; also expanding into ultrasound and AI-enabled breast imaging workflows.
• Mindray: Major global challenger in patient monitoring, ultrasound (LOGIQ/Vivid competitors), and in-vitro diagnostics; particularly strong in emerging markets and China where it competes with GE HealthCare.

Broad incumbents

• Medtronic: Broad incumbent medtech competitor in patient monitoring, surgical visualization, and image-guided therapy with overlapping offerings to GE HealthCare's Patient Care Solutions and Image Guiding Solutions segments.
• Stryker: Broad incumbent in surgical equipment, surgical imaging, and hospital infrastructure that overlaps with GE HealthCare's OEC C-arm, surgical visualization (BK Medical), and hospital operations offerings.
• Johnson & Johnson MedTech (Biosense Webster): Distributes GE HealthCare's 4D ICE NUVISION catheter in combination with Vivid E95/S70N ultrasound; broader competitor in image-guided interventional cardiology and surgery where Allia IGS competes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/gehealthcare
• Facebookfacebook.com/GEHealthcare
• LinkedInlinkedin.com/company/gehealthcare
• Instagraminstagram.com/gehealthcare
• Xx.com/GEHealthcare

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries6 records

Funding overview

Funding rounds6 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A47 records

Investments28 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GE Healthcare